Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03326713 · ClinicalTrials.gov registry record · NA
Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 668
- Enrollment target
NCT03326713 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 668 participants.
The verdict
NCT03326713, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 668 participants
- Enrollment target
Study Summary
GRACE is a randomized 3-arm trial to determine the comparative effectiveness of two remote cancer communication interventions: 1) a targeted generic print (TP) or 2) a tailored telephone-based counseling and navigation intervention (TCN). Post-award, the target sample size was revised to (n=642) with NIH permission.
Interventions
- OTHER Usual Care (UC)
- BEHAVIORAL Telephone Counseling & Navigation (TCN)
- BEHAVIORAL Mailed Targeted Print (TP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 668 participants |
| Start Date | 2017-11-02 |
| Est. Completion | 2022-06-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03326713
The ClinicalTrials.gov registry entry for NCT03326713 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 668 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Usual Care (UC) is the first listed.
NCT03326713 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03326713 about?
NCT03326713 is a clinical study titled "Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project". GRACE is a randomized 3-arm trial to determine the comparative effectiveness of two remote cancer communication interventions: 1) a targeted generic print (TP) or 2) a tailored telephone-based counseling and navigation intervention (TCN). Post-award, the target sample size was revised to (n=642) wit...
What is the current status of trial NCT03326713?
This trial is currently completed. It is a NA study. The enrollment target is 668 participants. The study started on 2017-11-02. Estimated completion is 2022-06-02.
What interventions are being tested in trial NCT03326713?
The interventions under investigation include: Usual Care (UC) (OTHER), Telephone Counseling & Navigation (TCN) (BEHAVIORAL), Mailed Targeted Print (TP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03326713?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.